BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 16324957)

  • 1. Long-term quality of life and uncertainty in patients living with an implantable cardioverter defibrillator.
    Flemme I; Edvardsson N; Hinic H; Jinhage BM; Dalman M; Fridlund B
    Heart Lung; 2005; 34(6):386-92. PubMed ID: 16324957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes, problems and quality of life with the implantable cardioverter defibrillator.
    Reid SS; McKinley S; Nagy S
    Aust J Adv Nurs; 1999; 16(4):14-9. PubMed ID: 10603767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partner quality of life in the antiarrhythmics versus implantable defibrillators trial.
    Jenkins LS; Powell JL; Schron EB; McBurnie MA; Bosworth-Farrell S; Moore R; Exner DV;
    J Cardiovasc Nurs; 2007; 22(6):472-9. PubMed ID: 18090188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ICD: a qualitative study of patient experience the first year after implantation.
    Kamphuis HC; Verhoeven NW; Leeuw R; Derksen R; Hauer RN; Winnubst JA
    J Clin Nurs; 2004 Nov; 13(8):1008-16. PubMed ID: 15533107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring uncertainty and psychosocial adjustment after cardioverter defibrillator implantation.
    Mauro AM
    J Cardiovasc Nurs; 2008; 23(6):527-35. PubMed ID: 18953218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychosocial factors and quality of life in children and adolescents with implantable cardioverter-defibrillators.
    DeMaso DR; Lauretti A; Spieth L; van der Feen JR; Jay KS; Gauvreau K; Walsh EP; Berul CI
    Am J Cardiol; 2004 Mar; 93(5):582-7. PubMed ID: 14996583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posttraumatic stress symptoms and predicted mortality in patients with implantable cardioverter-defibrillators: results from the prospective living with an implanted cardioverter-defibrillator study.
    Ladwig KH; Baumert J; Marten-Mittag B; Kolb C; Zrenner B; Schmitt C
    Arch Gen Psychiatry; 2008 Nov; 65(11):1324-30. PubMed ID: 18981344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uncertainty as a predictor of adjustment to an implantable cardioverter defibrillator.
    Mauro AM
    Prog Cardiovasc Nurs; 2008; 23(4):151-9. PubMed ID: 19067978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychological and clinical problems in young adults with implantable cardioverter-defibrillators.
    Wójcicka M; Lewandowski M; Smolis-Bak E; Szwed H
    Kardiol Pol; 2008 Oct; 66(10):1050-8; discussion 1059-60. PubMed ID: 19006026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effects of implanted cardioverter-defibrillators on health status, quality of life, and psychological state.
    Carroll DL; Hamilton GA
    Am J Crit Care; 2008 May; 17(3):222-30; quiz 231. PubMed ID: 18450679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type-D personality but not implantable cardioverter-defibrillator indication is associated with impaired health-related quality of life 3 months post-implantation.
    Pedersen SS; Theuns DA; Muskens-Heemskerk A; Erdman RA; Jordaens L
    Europace; 2007 Aug; 9(8):675-80. PubMed ID: 17434891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender disparities in anxiety and quality of life in patients with an implantable cardioverter-defibrillator.
    Habibović M; van den Broek KC; Theuns DA; Jordaens L; Alings M; van der Voort PH; Pedersen SS
    Europace; 2011 Dec; 13(12):1723-30. PubMed ID: 21821854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related quality of life of patients with implantable cardioverter defibrillators compared with that of pacemaker recipients.
    Leosdottir M; Sigurdsson E; Reimarsdottir G; Gottskalksson G; Torfason B; Vigfusdottir M; Eggertsson S; Arnar DO
    Europace; 2006 Mar; 8(3):168-74. PubMed ID: 16627433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiological and psychosocial status of patients with malignant ventricular arrhythmias before implantation of a cardioverter defibrillator. First results from the German Austrian ICD Multicenter Study (GAIMS)].
    Herrmann-Lingen C; Fritzsche K; Kanwischer H; Drinkmann A; Rabung S; Bergmann G;
    Psychother Psychosom Med Psychol; 2004 Aug; 54(8):308-19. PubMed ID: 15284942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The quality of life after the implantation of a cardioverter/defibrillator in malignant arrhythmias].
    Lüderitz B; Jung W; Deister A; Marneros A; Manz M
    Dtsch Med Wochenschr; 1993 Mar; 118(9):285-9. PubMed ID: 8444109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of an implantable cardioverter defibrillator with atrial detection and shock therapies on patient-perceived, health-related quality of life.
    Newman DM; Dorian P; Paquette M; Sulke N; Gold MR; Schwartzman DS; Schaaf K; Wood K; Johnson L;
    Am Heart J; 2003 May; 145(5):841-6. PubMed ID: 12766741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life among implantable cardioverter-defibrillator recipients in the primary prevention therapeutic era.
    Groeneveld PW; Matta MA; Suh JJ; Yang F; Shea JA
    Pacing Clin Electrophysiol; 2007 Apr; 30(4):463-71. PubMed ID: 17437568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sexual dysfunction, depression and quality of life in male implantable cardioverter defibrillator (ICD) recipients--with and without shock delivery].
    Shiyovich A; Ben Zion IZ; Plakht Y; Amit G; Grosbard A; Katz A
    Harefuah; 2007 Aug; 146(8):594-8, 647. PubMed ID: 17853553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Course of anxiety and device-related concerns in implantable cardioverter defibrillator patients the first year post implantation.
    Pedersen SS; Theuns DA; Jordaens L; Kupper N
    Europace; 2010 Aug; 12(8):1119-26. PubMed ID: 20507853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.